CFR section

21 CFR 211.142(b): Warehousing procedures

PART 211-CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS · Subpart H-Holding and Distribution

Key facts

Citation 21 CFR 211.142(b)
Section Warehousing procedures
Part PART 211-CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
Subpart Subpart H-Holding and Distribution
Subchapter 21 CFR C Drugs General
Product types cited Biologics, Devices, Drugs, Food/Cosmetics, General, Other_Regulations, Veterinary
Regulation text (excerpt) (b) Storage of drug products under appropriate conditions of temperature, humidity, and light so that the identity, strength, quality, and purity of the drug products are not affected.

At a glance

  • 100–999 Inspections citing this section
  • 10–99 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA